Literature DB >> 3370994

Selective toxicity of gossypol against epithelial tumors and its detection by magnetic resonance spectroscopy.

C Benz1, M Keniry, H Goldberg.   

Abstract

The antitumor toxicity of gossypol was measured in 6 human carcinoma cell lines and compared with its toxicity against human bone marrow stem cells. Marrow cells were more resistant than any of the tumor cell lines, and tumor cell sensitivity depended on the content of intracellular LDH-M. [31P]-Magnetic resonance spectroscopy showed decline in tumor ATP levels occurring within 24 hours of treatment, suggesting that this non-invasive technique may serve as an early biochemical monitor of gossypol toxicity.

Entities:  

Keywords:  Cancer; Clinical Research; Contraception; Contraceptive Agents, Male--pharmacodynamics; Contraceptive Agents--pharmacodynamics; Diseases; Family Planning; Gossypol--pharmacodynamics; In Vitro; Neoplasms; Research Methodology; Treatment

Mesh:

Substances:

Year:  1988        PMID: 3370994     DOI: 10.1016/0010-7824(88)90024-8

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  4 in total

Review 1.  An overview of the clinical pharmacology and therapeutic potential of gossypol as a male contraceptive agent and in gynaecological disease.

Authors:  D Wu
Journal:  Drugs       Date:  1989-09       Impact factor: 9.546

2.  A preliminary clinical study of gossypol in advanced human cancer.

Authors:  R C Stein; A E Joseph; S A Matlin; D C Cunningham; H T Ford; R C Coombes
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

3.  In vitro and in vivo cytotoxicity of gossypol against central nervous system tumor cell lines.

Authors:  T Coyle; S Levante; M Shetler; J Winfield
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

4.  Preclinical Efficacy and Toxicity Analysis of the Pan-Histone Deacetylase Inhibitor Gossypol for the Therapy of Colorectal Cancer or Hepatocellular Carcinoma.

Authors:  Mascha Mayer; Alexander Berger; Christian Leischner; Olga Renner; Markus Burkard; Alexander Böcker; Seema Noor; Timo Weiland; Thomas S Weiss; Christian Busch; Ulrich M Lauer; Stephan C Bischoff; Sascha Venturelli
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.